Showing results (551-560 of 2,514) with videos related to

Sort By:
Pageof 252
Inflammopharmacology|March 23, 2025
Unveiling the neuroprotective potential of Jatropha humboldtiana leaves and its metabolic profiling by UPLC-MS/MSPaul Alan Arkin Alvarado-García, Marilú Roxana Soto-Vásquez, Ricardo D D G de Albuquerque, et al.
Inflammopharmacology|May 30, 2024
Progress in the treatment of Osteoarthritis with avocado-soybean unsaponifiableYong-Ze Yang, Qing-Hao Cheng, An-Ren Zhang, et al.
Inflammopharmacology|July 19, 2024
Trivalent chromium versus baricitinib for rheumatoid arthritis treatment: first phase 2/3 randomized controlled trial, is trivalent chromium the upcoming immune-modulator?Sally S Hassouna, Omneya Mohamed-Ayman Abdel-Moniem
Inflammopharmacology|May 19, 2024
Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in ratsHoda A Abd-Ellatieff, Kristen Georg, Abdel-Rahman A Abourawash, et al.
Inflammopharmacology|June 22, 2024
Topical diosmetin attenuates nociception and inflammation in a ultraviolet B radiation-induced sunburn model in miceAmanda Favarin, Gabriela Becker, Evelyne Silva Brum, et al.
Inflammopharmacology|May 16, 2024
Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysisMengye Wu, Cuiping Li, Xue Zhou, et al.
Inflammopharmacology|December 17, 2025
SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximinTaghreed N Almanaa, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Inflammopharmacology|December 15, 2025
A systematic review of therapeutic and paradoxical roles of tumor necrosis factor α inhibitors in autoimmune blistering diseasesYekta Ghane, Ali Ezzatollahi Tanha, Mina Khosravi, et al.
Inflammopharmacology|December 15, 2025
Ivarmacitinib provides rapid and continuous improvement in patients with moderate-to-severe atopic dermatitis: a focus on different anatomical regionsFeng Xiong, Bingjing Zhou, Siting Huang, et al.
Inflammopharmacology|December 15, 2025
Fluvoxamine attenuates inflammation in experimental sepsis via novel non-canonical pathwaysLuis H A Costa, Isis P Trajano, Wanderson S Santos, et al.
Pageof 252